The FDA said Walgreens has addressed violations related to drug listing deficiencies for one of its products, according to a Dec. 19 close-out letter. The agency previously cited Walgreens in ...
A package of Wegovy by Novo Nordisk sits on a table in Copenhagen, Denmark, in 2023. The FDA is cracking down on ingredients from potentially dangerous active ingredients used in GLP-1 drugs that ...
In 2025, the U.S. Food and Drug Administration (FDA or the Agency) issued a surprising number of enforcement letters to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results